Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
CNS Pharmaceuticals, Inc. (CNSP) had Debt to Equity Ratio of 0.02 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-4.30M |
|
-- |
|
-- |
|
$4.34M |
|
$-4.34M |
|
$0.04M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-4.30M |
|
$-4.34M |
|
$-4.34M |
|
2.73M |
|
2.73M |
|
$-1.58 |
|
$-1.58 |
|
| Balance Sheet Financials | |
$13.72M |
|
$0.00M |
|
$0.03M |
|
$13.75M |
|
$2.78M |
|
-- |
|
-- |
|
$2.78M |
|
$10.97M |
|
$10.97M |
|
$10.97M |
|
2.94M |
|
| Cash Flow Statement Financials | |
$-3.24M |
|
-- |
|
$9.83M |
|
$6.46M |
|
$13.05M |
|
$6.59M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.94 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.02 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.21% |
|
-39.21% |
|
-31.28% |
|
-39.21% |
|
$3.73 |
|
$-1.19 |
|
$-1.19 |
|